Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive Bladder Cancer (MIBC)”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Looking for participantsNCT07296705
What this trial is testing

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital 25
Testing effectiveness (Phase 2)UnknownNCT03993249
What this trial is testing

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Who this might be right for
Bladder Cancer
Hellenic GenitoUrinary Cancer Group 78
Testing effectiveness (Phase 2)Looking for participantsNCT05072600
What this trial is testing

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder NeoplasmsBladder Tumors+2 more
Peking University First Hospital 54
Testing effectiveness (Phase 2)Looking for participantsNCT06417190
What this trial is testing

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Who this might be right for
Muscle-Invasive Bladder CarcinomaTumor
Leslie Ballas 20
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Not applicableUnknownNCT05097404
What this trial is testing

Clinical Utility of VI-RADS in Diagnosis of MIBC

Who this might be right for
Radical CystectomyMuscle-Invasive Bladder CarcinomaMultiparametric MRI+1 more
Samsung Medical Center 73
Not applicableNot Yet RecruitingNCT06325423
What this trial is testing

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Assiut University 50
Testing effectiveness (Phase 2)UnknownNCT04047693
What this trial is testing

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder CancerUrothelial CarcinomaNeoadjuvant Chemotherapy
Pusan National University Yangsan Hospital 32
Early research (Phase 1)Active Not RecruitingNCT04610671
What this trial is testing

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Not applicableStudy completedNCT02203136
What this trial is testing

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)Looking for participantsNCT07067749
What this trial is testing

Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder Cancer Requiring CystectomyBladder Carcinoma+2 more
University of Rome Tor Vergata 92
Testing effectiveness (Phase 2)Study completedNCT03636256
What this trial is testing

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more
NanOlogy, LLC 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06623162
What this trial is testing

Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients

Who this might be right for
MibcMuscle Invasive Bladder Cancer
Fundación de investigación HM 70
Testing effectiveness (Phase 2)Looking for participantsNCT06682728
What this trial is testing

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence

Who this might be right for
Urothelial CarcinomaMuscle-invasive Bladder Cancer
University of California, Irvine 23
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Not applicableLooking for participantsNCT07225205
What this trial is testing

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerMuscle Invasive Bladder Cancer (MIBC)Muscle Invasive Bladder Cancer Urothelial Carcinoma+1 more
Johns Hopkins University 130
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Large-scale testing (Phase 3)Active Not RecruitingNCT04658862
What this trial is testing

TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 518
Large-scale testing (Phase 3)Active Not RecruitingNCT03732677
What this trial is testing

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 1,063
Load More Results